Total Payments
$5,410
2024 Payments
$639.19
Companies
32
Transactions
350
Medicare Patients
4,546
Medicare Billing
$363,931
Payment Breakdown by Category
Food & Beverage$5,404 (99.9%)
Education$6.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,404 | 349 | 99.9% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,267 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $645.69 | 46 | $0 (2024) |
| Lilly USA, LLC | $468.70 | 27 | $0 (2024) |
| Amgen Inc. | $354.83 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $317.86 | 20 | $0 (2021) |
| GlaxoSmithKline, LLC. | $292.78 | 19 | $0 (2020) |
| PFIZER INC. | $276.43 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $226.42 | 15 | $0 (2022) |
| Allergan, Inc. | $200.97 | 12 | $0 (2020) |
| Merck Sharp & Dohme LLC | $185.13 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $639.19 | 32 | Novo Nordisk Inc ($221.75) |
| 2023 | $385.77 | 19 | Novo Nordisk Inc ($115.98) |
| 2022 | $124.53 | 5 | ABBVIE INC. ($57.32) |
| 2021 | $228.59 | 14 | Lilly USA, LLC ($90.87) |
| 2020 | $459.95 | 30 | Novo Nordisk Inc ($99.29) |
| 2019 | $888.19 | 57 | Novo Nordisk Inc ($245.20) |
| 2018 | $1,168 | 80 | Novo Nordisk Inc ($242.01) |
| 2017 | $1,516 | 113 | Novo Nordisk Inc ($289.88) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Obesity | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.02 | General |
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Obesity | ||||||
| 07/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: PAIN | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: PAIN | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Obesity | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Gastroenterology | ||||||
| 05/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Endocrinology | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,212 | 1,895 | $282,211 | $80,456 |
| 2022 | 19 | 1,045 | 1,607 | $276,944 | $83,107 |
| 2021 | 16 | 1,047 | 1,762 | $355,022 | $100,434 |
| 2020 | 19 | 1,242 | 2,217 | $422,856 | $99,933 |
Total Patients
4,546
Total Services
7,481
Medicare Billing
$363,931
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 470 | $164,500 | $41,436 | 25.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 96 | 96 | $28,800 | $12,844 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 86 | $18,060 | $5,480 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 26 | $10,400 | $3,706 | 35.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 46 | 46 | $5,750 | $2,774 | 48.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 81 | 82 | $3,690 | $2,650 | 71.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 127 | 249 | $5,976 | $2,092 | 35.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 101 | 101 | $6,060 | $1,923 | 31.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 80 | 81 | $4,455 | $1,772 | 39.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 88 | 93 | $11,625 | $1,015 | 8.7% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 53 | 95 | $2,375 | $904.40 | 38.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 42 | $2,352 | $781.87 | 33.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 23 | 25 | $2,250 | $672.24 | 29.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 76 | 89 | $4,450 | $543.79 | 12.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 12 | $1,140 | $516.96 | 45.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 80 | 101 | $3,333 | $513.08 | 15.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $495.00 | $355.52 | 71.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 99 | 155 | $3,875 | $341.00 | 8.8% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 19 | 35 | $2,625 | $134.75 | 5.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 462 | $161,700 | $40,225 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 106 | 106 | $31,800 | $14,546 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 92 | $19,320 | $5,913 | 30.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 55 | 55 | $6,875 | $3,582 | 52.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 24 | 24 | $4,800 | $3,150 | 65.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 12 | 44 | $7,260 | $2,748 | 37.9% |
About Dr. Shishir Jain, M.D
Dr. Shishir Jain, M.D is a Internal Medicine healthcare provider based in Cicero, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811085822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shishir Jain, M.D has received a total of $5,410 in payments from pharmaceutical and medical device companies, with $639.19 received in 2024. These payments were reported across 350 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,404).
As a Medicare-enrolled provider, Jain has provided services to 4,546 Medicare beneficiaries, totaling 7,481 services with total Medicare billing of $363,931. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cicero, IL
- Active Since 10/11/2006
- Last Updated 06/19/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811085822
Products in Payments
- Victoza (Drug) $327.21
- XARELTO (Drug) $299.86
- FARXIGA (Drug) $262.80
- TRULICITY (Drug) $250.11
- Ozempic (Drug) $224.86
- Tresiba (Drug) $200.11
- Prolia (Biological) $159.16
- ELIQUIS (Drug) $155.43
- Wegovy (Drug) $140.13
- SYMBICORT (Drug) $136.98
- CHANTIX (Drug) $133.11
- Rybelsus (Drug) $129.31
- SOLIQUA (Drug) $122.13
- BYDUREON (Drug) $117.81
- Trintellix (Drug) $117.11
- Saxenda (Drug) $114.35
- QULIPTA (Drug) $109.00
- ENTRESTO (Drug) $107.39
- Aimovig (Biological) $104.96
- TRELEGY ELLIPTA (Drug) $97.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cicero
Dr. Manish Desai, D.o, D.O
Internal Medicine — Payments: $10,124
Internal Medicine $10,124
Dr. Sabiha Thaseen, M.d, M.D
Internal Medicine — Payments: $67.46
Internal Medicine $67.46
Dr. Ishver Desai, M.d, M.D
Internal Medicine — Payments: $52.97
Internal Medicine $52.97
Juan Huerta
Internal Medicine — Payments: $15.40
Internal Medicine $15.40
Deepak Leekha, Md, MD
Internal Medicine
Internal Medicine
Dr. Ramnik Gokani, M.d, M.D
Internal Medicine
Internal Medicine